APA Citatie

Sarangarajan, R., Winn, R., Kiebish, M. A., Bountra, C., Granger, E., & Narain, N. R. (2020). Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers. J Racial Ethn Health Disparities.

Chicago Style citaat

Sarangarajan, Rangaprasad, Robert Winn, Michael A. Kiebish, Chas Bountra, Elder Granger, en Niven R. Narain. "Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers." J Racial Ethn Health Disparities 2020.

MLA citatie

Sarangarajan, Rangaprasad, et al. "Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers." J Racial Ethn Health Disparities 2020.